Cargando…
Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
Obesity, generally characterized by excessive lipid accumulation, is a metabolic threat worldwide due to its rapid growth in global prevalence. Ginsenosides are crucial components derived from natural plants that can confer metabolic benefits for obese patients. Considering the low bioavailability a...
Autores principales: | Zhuang, Tongxi, Li, Wei, Yang, Li, Wang, Zhengtao, Ding, Lili, Zhou, Mingmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429618/ https://www.ncbi.nlm.nih.gov/pubmed/34512356 http://dx.doi.org/10.3389/fphar.2021.731288 |
Ejemplares similares
-
Dose-Related Urinary Metabolic Alterations of a Combination of Quercetin and Resveratrol-Treated High-Fat Diet Fed Rats
por: Zhuang, Tongxi, et al.
Publicado: (2021) -
Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022) -
Ginsenosides: Allies of gastrointestinal tumor immunotherapy
por: Feng, Yutao, et al.
Publicado: (2022) -
Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022) -
Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation
por: Chen, Zhaoqiang, et al.
Publicado: (2022)